Delisting risk
NXGL · NASDAQ · Medical - Instruments & Supplies

NexGel (NXGL)

Manufactures customizable hydrogels and sells consumer, white-label, and licensed surgical biomaterials.

$0.3750
Pre-market+0.02 (+6.35%)
At close$0.3526(−1.51%)

Breakdown13F · 13D/G · Form 4

Institutions17 holders · as of Mar 31, 20265.98%506.6K shares
Insiders8 holders · as of Jun 23, 202615.00%1.27M shares
Otherremainder79.02%6.70M shares

8.48M company shares as of Aug 22, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (9.75M in the company's Sep 3, 2026 report, 8.48M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Asymmetry Point LPInstitution
8.79%745,00013Gfiled Apr 29, 2026
John Nachum SteinInsiderdirector
5.56%471,456Form 4filed Nov 22, 2024
Adam R. LevyInsiderdirector, officer: Chief Executive Officer
3.81%322,692Form 4filed Jun 23, 2026
steven mark glassmanInsiderdirector
1.85%156,655Form 4filed Feb 12, 2025
Geode Capital Management, LLCInstitution
1.52%128,53613Fas of Mar 31, 2026
Scott Robert HenryInsiderdirector
1.34%113,356Form 4filed Oct 6, 2025
Jerome B. ZeldisInsiderdirector
1.26%106,664Form 4filed Nov 22, 2024
Adam E. III DrapczukInsiderofficer: Chief Financial Officer
0.88%74,894Form 4filed Nov 22, 2024
Morgan StanleyInstitution
0.65%54,98013Fas of Mar 31, 2026
Renaissance Technologies LLCInstitution
0.60%50,96013Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution
0.58%48,92013Fas of Mar 31, 2026
Jane Street Group, LLCInstitution
0.50%42,13813Fas of Mar 31, 2026
Simon Quick Advisors, LLCInstitution
0.42%35,71513Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.40%34,04013Fas of Mar 31, 2026
Steven CiardielloInsiderdirector
0.26%21,739Form 4filed Aug 5, 2025
Flax Pond Capital, LLCInstitution
0.24%20,00013Fas of Mar 31, 2026
GTS Securities LLCInstitution
0.23%19,34713Fas of Mar 31, 2026
XTX Topco LtdInstitution
0.21%17,58513Fas of Mar 31, 2026
State Street CorpInstitution
0.20%17,25913Fas of Mar 31, 2026
HRT Financial LPInstitution
0.18%15,49613Fas of Mar 31, 2026
HBK Sorce Advisory LLCInstitution
0.15%12,50013Fas of Mar 31, 2026
UBS Group AGInstitution
0.08%6,63413Fas of Mar 31, 2026
Joseph F. McguireInsiderofficer: Chief Financial Officer
0.05%4,082Form 4filed Jan 6, 2025
Tower Research Capital LLC (TRC)Institution
0.03%2,16213Fas of Mar 31, 2026
Advisor Group Holdings, Inc.Institution
0.00%30513Fas of Mar 31, 2026

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

17 holders · 506.6K shares · 6 new positions · 11 increased · 2 reduced · 9 closed

HolderShares% outstandingChg q/qFiled
Geode Capital Management, LLC128.5K1.52%+61.5KMay 15, 2026
Morgan Stanley55.0K0.65%−30.4KMay 15, 2026
Renaissance Technologies LLC51.0K0.60%−4.3KMay 14, 2026
Vanguard Capital Management LLC48.9K0.58%+48.9KnewMay 15, 2026
Jane Street Group, LLC42.1K0.50%+12.7KMay 12, 2026
Simon Quick Advisors, LLC35.7K0.42%0May 6, 2026
Vanguard Fiduciary Trust Co34.0K0.40%+34.0KnewMay 15, 2026
Flax Pond Capital, LLC20.0K0.24%+20.0KnewMay 19, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Asymmetry Point LP8.80%745.0K13GApr 29, 2026

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Jun 23, 2026
Adam R. Levydirector, officer: Chief Executive Officer
Sale5,000$0.5933322,692
Jun 18, 2026
Adam R. Levydirector, officer: Chief Executive Officer
Sale6,000$0.5921327,692
Jun 11, 2026
Adam R. Levydirector, officer: Chief Executive Officer
Sale3,000$0.6136333,692
Jun 8, 2026
Adam R. Levydirector, officer: Chief Executive Officer
Sale3,000$0.5470336,692
Jun 4, 2026
Adam R. Levydirector, officer: Chief Executive Officer
Sale3,000$0.5936339,692
Jun 1, 2026
Adam R. Levydirector, officer: Chief Executive Officer
Sale2,000$0.5859342,692
May 29, 2026
Adam R. Levydirector, officer: Chief Executive Officer
Sale3,000$0.6003344,692
May 28, 2026
Adam R. Levydirector, officer: Chief Executive Officer
Sale7,000$0.6058347,692
May 27, 2026
Adam R. Levydirector, officer: Chief Executive Officer
Sale3,000$0.5975354,692
May 14, 2026
Adam R. Levydirector, officer: Chief Executive Officer
Purchase · 2 lots150,000$0.6667150,000

CongressHouse and Senate disclosures

Not reported.